Important notice: Direct Healthcare Professional Communication (DHPC) letters are primarily intended for healthcare professionals. Patients/caregivers who have questions or concerns about the safety information presented are advised to consult their doctor or pharmacist.
Direct Healthcare Professional Communication (DHPC) letters are issued by pharmaceutical companies to inform healthcare professionals about important safety information concerning medicinal products, and recommended measures to minimise the risks. DHPCs aim to support healthcare professionals in making informed decisions and ensuring the safe and appropriate use of medicines.
This webpage features only DHPCs evaluated by the Pharmacovigilance Section, NPRA, that communicate newly identified or emerging safety issues, or important safety updates issued as part of additional risk minimisation measures, requiring the attention or action of healthcare professionals.
For Healthcare Professionals only
DKSH Malaysia Sdn Bhd. has issued a DHPC letter related to a safety issue.
Are you a healthcare professional?